2 minute read
List of candidates for 2023 local general election released
from Vol. 65, Issue 7
by The Paisano
By Gauri Raje News Editor
The City of San Antonio has released the ballot order for the city’s general election in May.
Candidates had the opportunity to file for the elections until Feb. 17. In order to run for a municipal office, candidates have to be a U.S. citizen of at least 18 years of age and a qualified voter of the City of San Antonio by the filing deadline, among other requirements. Candidates also have to submit two different documents as proof of address.
According to an article by mysanantonio.com, none of the offices are uncontested, with a total of 58 candidates running for the different positions. A full list of candidates can be found at https://www.sanantonio.gov/ paracellular transport. Since the latter can increase the risk of infections like cholera, the team has focused on the transcellular mechanism.
ElectionsCampaignFinance/ City-Elections. here.
The 2023 general election is set to take place after the city’s redistricting process in 2022, which redrew the City Council districts. The current City Council approved the new district boundaries on June 16, 2022. Residents can utilize a new interactive mapping tool to verify their city council district.
Early voting begins Monday, April 24, 2023, and will run through Tuesday, May 2, 2023. Election day is scheduled for Saturday, May 6.
The last day to register to vote is Thursday, April 6, 2023. For more information about voter registration and polling locations in Bexar County, visit https:// www.bexar.org/1702/Registerto-Vote.
He also presented another application involving the delivery of proteins in the body to treat other diseases using a hydrogel to deliver molecules like insulin, human growth hormone and calcitonin. With respect to Crohn’s disease, Peppas presented research on an approach to treating it using siRNA molecules, which need to be delivered directly to cells. Finally, Peppas presented information and research on macular degeneration treatment.
Peppas’ team is also working on alternative ways to establish early diagnosis of multiple sclerosis.
In 2021, Peppas, along with colleagues and students, published a paper titled “Engineering precision nanoparticles for drug delivery” on this topic of precision medicine. The paper has been cited 1871 times.
“I want to tell you how important it is to publish the right paper in the right journal at the right time,” Peppas said. “People read it. It’s changing lives. It teaches them how to come up with better ways to treat.”
Peppas first presented research relating to the development of pH-sensitive selfassembled polymers, prepared using RAFT polymerization, that can be used to administer treatment for rheumatoid arthritis orally. His team also started working on the oral delivery of molecules like interferon beta, which is used to treat multiple sclerosis using transcellular and
Furthermore, through their research, Peppas’ team has created new biomaterials that are “responsive to the environment,” including factors like pH, light and temperature.
“These are the applications that lead to intelligence,” Peppas said. “We use [this word] because we truly believe that we can recognize what happens to the surrounding medium and we can lead to better solutions.”
Peppas also highlighted the health disparities worldwide as it relates to autoimmune diseases, healthcare checkups and screening. According to Peppas, autoimmune diseases often tend to appear in individuals that do not have “regular medical background treatment.”
Concerning multiple sclerosis, Peppas explained that the disease tends to appear “dominantly” in women, adding that autoimmune diseases are the eighth leading cause of death in women ages 15 to 64.
Furthermore, Peppas pointed out the lack of early detection and treatment of severe diseases. This can occur due to a lack of understanding regarding the early signs of disease, making health disparities affecting women and minority populations even more apparent.
“[As engineers], we have to give answers,” Peppas said. “We have to come up with better biosensors that will recognize certain biomolecules [allowing for better detection of diseases or its tendency in individuals].”
“I seriously believe that quality of life with intelligent materials is a must,” Peppas concluded.